Build, Buy or Licence? What Bayer’s Hybrid Wheat Deal Teaches About IP Licensing Strategy
Some assets cannot be built on any timeline a budget can shorten. When that is true, the choice is no longer build, buy or licence. It is licence, or stay out. Bayer’s move into hybrid wheat this year is a clean example, and a useful…

